🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.23
-0.46 (-5.29%)
Nov 18, 2026, 4:00 PM EST - Market closed

Enanta Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22
Net Income
-81.89-116.05-133.82-121.76
Depreciation & Amortization
4.592.342.372.97
Loss (Gain) From Sale of Assets
0.010.020.15-
Loss (Gain) From Sale of Investments
0.5-1.14-2.930.33
Stock-Based Compensation
18.5726.828.2226.97
Other Operating Activities
-0.952.14-5.17-0.08
Change in Accounts Receivable
-0.241.9711.73.26
Change in Accounts Payable
-1.31-0.41-1.15-4.63
Change in Income Taxes
32-1-2.298.54
Change in Other Net Operating Assets
9.466.57-0.24-0.37
Operating Cash Flow
-19.27-78.76-103.15-84.78
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22
Capital Expenditures
-12.9-17.95-9.06-2.13
Investment in Securities
53.2476.18-44.5257.02
Investing Cash Flow
40.3558.24-53.5854.9

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22
Issuance of Common Stock
0.150.152.2121.26
Other Financing Activities
-26.76-27.77195.92-1.23
Financing Cash Flow
-26.62-27.63198.1320.03

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22
Net Cash Flow
-5.54-48.1641.39-9.85

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22
Free Cash Flow
-32.17-96.71-112.21-86.91
Free Cash Flow Growth
----
Free Cash Flow Margin
-49.24%-142.99%-141.67%-100.87%
Free Cash Flow Per Share
-1.51-4.57-5.35-4.22
Levered Free Cash Flow
-18.54-71.38-62.34-42.08
Unlevered Free Cash Flow
-13.74-64.55-59.13-42.08

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22
Cash Interest Paid
8.7911.711.99-
Cash Income Tax Paid
-33.680.244.9-
Change in Working Capital
39.917.138.026.79
SEC Filings: 10-K · 10-Q